Vorolanib
Vorolanib Uses, Dosage, Side Effects, Food Interaction and all others data.
Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).
Trade Name | Vorolanib |
Generic | Vorolanib |
Vorolanib Other Names | Vorolanib |
Type | |
Formula | C23H26FN5O3 |
Weight | Average: 439.491 Monoisotopic: 439.20196788 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Vorolanib